Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis

Objectives To compare the risk of cardiovascular events from the initiation of therapy between metformin and dipeptidyl peptidase-4 inhibitors (DPP-4i) as first-line therapy.Design Retrospective cohort study using two claims databases.Setting The MDV database (provided by Medical Data Vision) compri...

Full description

Saved in:
Bibliographic Details
Main Authors: Rimei Nishimura, Tomomi Takeshima, Kosuke Iwasaki, Sumiko Aoi
Format: Article
Language:English
Published: BMJ Publishing Group 2022-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/3/e045966.full
Tags: Add Tag
No Tags, Be the first to tag this record!